Chromobacterium violaceum

Last updated

Chromobacterium violaceum
Chromobacterium violaceum blood agar.jpg
Blood agar plate culture of C. violaceum. Image from the CDC.
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Pseudomonadota
Class: Betaproteobacteria
Order: Neisseriales
Family: Neisseriaceae
Genus: Chromobacterium
Species:
C. violaceum
Binomial name
Chromobacterium violaceum
(Bergonzini 1880)

Chromobacterium violaceum is a Gram-negative, facultative anaerobic, non-sporing coccobacillus. It is motile with the help of a single flagellum which is located at the pole of the coccobacillus. Usually, there are one or two more lateral flagella as well. [1] It is part of the normal flora of water and soil of tropical and sub-tropical regions of the world. It produces a natural antibiotic called violacein , which may be useful for the treatment of colon and other cancers. [2] It grows readily on nutrient agar, producing distinctive smooth low convex colonies with a characteristic striking dark violet metallic sheen (due to violacein production). [3] Some strains of the bacteria which do not produce this pigment have also been reported. [4] It has the ability to break down tarballs. [5]

Contents

Biochemistry

C. violaceum ferments glucose, trehalose, N-acetylglucosamine and gluconate but not L-arabinose, D-galactose, or D-maltose. It is positive for catalase and oxidase reactions. [1] Bacterial isolates in many cases can show high level resistance to a range of antibiotics. [6]

Medical significance

C. violaceum rarely infects humans, but when it does it causes skin lesions, sepsis, and liver abscesses that may be fatal. [7] The first reported case of Chromobacterium violaceum infection in humans in literature is from Malaysia in 1927. [1] Only 150 cases have been reported in literature since then. [8] To date, cases have been reported from Argentina, Australia, Brazil, Canada, Cuba, India, Japan, Nigeria, Singapore, Sri Lanka, Taiwan, United States and Vietnam. The most common mode of entry of the bacteria into the body is through the injured skin coming in contact with soil or water containing the bacteria. [1] [9] The disease usually starts as a limited infection of the skin at the point of entry of the bacteria, which progresses to necrotizing metastatic lesions, then multiple abscesses of the liver, lung, spleen, skin, lymph nodes or brain, leading to severe septicaemia, culminating in multiorgan failure which may be fatal. [10] Other reported pathologies include chronic granulomatosis, osteomyelitis, cellulitis, diarrhoea, septic spondylitis, conjunctivitis, periorbital and ocular infection. [1] [11] [12] [13] [14] Care must be taken because Burkholderia pseudomallei is commonly misidentified as C. violaceum by many common identification methods. [15] [16] The two are readily distinguished because B. pseudomallei produces large wrinkled colonies, whereas C. violaceum produces a distinctive violet pigment.

C. violaceum produces a number of natural antibiotics:

It has been described as a cause of infection in gibbons. [17]

Treatment

Infection caused by C. violaceum is rare, therefore there are no clinical trials evaluating different treatments. Antibiotics that have been used to successfully treat C. violaceum include pefloxacin, [4] ciprofloxacin, amikacin, [1] and co-trimoxazole. [18] Other antibiotics that appear to be effective in vitro include chloramphenicol and tetracycline. [19] For theoretical reasons, infection would not be expected to respond to penicillins, cephalosporins, or aztreonam, although carbapenems like meropenem or imipenem may possibly work. [20] Though the bacteria is reported to be resistant to first generation cephalosporins, susceptibility to the newer cephalosporins is variable. [21]

Genome

The complete genome was sequenced and the results were published in 2003. C. violaceum type strain ATCC 12472 was found to have 4,751,080 base pairs with a G + C content of 64.83% and 4,431 ORFs. [3]

Related Research Articles

<span class="mw-page-title-main">Streptococcal pharyngitis</span> Medical condition

Streptococcal pharyngitis, also known as streptococcal sore throat, is pharyngitis caused by Streptococcus pyogenes, a gram-positive, group A streptococcus. Common symptoms include fever, sore throat, red tonsils, and enlarged lymph nodes in the front of the neck. A headache and nausea or vomiting may also occur. Some develop a sandpaper-like rash which is known as scarlet fever. Symptoms typically begin one to three days after exposure and last seven to ten days.

<span class="mw-page-title-main">Melioidosis</span> Human disease

Melioidosis is an infectious disease caused by a gram-negative bacterium called Burkholderia pseudomallei. Most people exposed to B. pseudomallei experience no symptoms; however, those who do experience symptoms have signs and symptoms that range from mild, such as fever and skin changes, to severe with pneumonia, abscesses, and septic shock that could cause death. Approximately 10% of people with melioidosis develop symptoms that last longer than two months, termed "chronic melioidosis".

<i>Acinetobacter</i> Genus of bacteria

Acinetobacter is a genus of Gram-negative bacteria belonging to the wider class of Gammaproteobacteria. Acinetobacter species are oxidase-negative, exhibit twitching motility, and occur in pairs under magnification.

<span class="mw-page-title-main">Aztreonam</span> Chemical compound

Aztreonam, sold under the brand name Azactam among others, is an antibiotic used primarily to treat infections caused by gram-negative bacteria such as Pseudomonas aeruginosa. This may include bone infections, endometritis, intra abdominal infections, pneumonia, urinary tract infections, and sepsis. It is given by intravenous or intramuscular injection or by inhalation.

<i>Bartonella</i> Genus of bacteria

Bartonella is a genus of Gram-negative bacteria. It is the only genus in the family Bartonellaceae. Facultative intracellular parasites, Bartonella species can infect healthy people, but are considered especially important as opportunistic pathogens. Bartonella species are transmitted by vectors such as ticks, fleas, sand flies, and mosquitoes. At least eight Bartonella species or subspecies are known to infect humans.

Streptococcus suis is a peanut-shaped, Gram-positive bacterium, and an important pathogen of pigs. Endemic in nearly all countries with an extensive pig industry, S. suis is also a zoonotic disease, capable of transmission to humans from pigs.

<span class="mw-page-title-main">Lung abscess</span> Medical condition

Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities containing necrotic debris or fluid caused by microbial infection.

<span class="mw-page-title-main">Carbapenem</span> Class of highly effective antibiotic agents

Carbapenems are a class of very effective antibiotic agents most commonly used for the treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.

<i>Burkholderia cepacia</i> complex Species of bacterium

Burkholderia cepacia complex (BCC), or simply Burkholderia cepacia, is a group of catalase-producing, lactose-nonfermenting, Gram-negative bacteria composed of at least 20 different species, including B. cepacia, B. multivorans, B. cenocepacia, B. vietnamiensis, B. stabilis, B. ambifaria, B. dolosa, B. anthina, B. pyrrocinia and B. ubonensis. B. cepacia is an opportunistic human pathogen that most often causes pneumonia in immunocompromised individuals with underlying lung disease. Patients with sickle-cell haemoglobinopathies are also at risk. The species complex also attacks young onion and tobacco plants, and displays a remarkable ability to digest oil. Burkholderia cepacia is also found in marine environments and some strains of Burkholderia cepacia can tolerate high salinity. S.I. Paul et al. (2021) isolated and biochemically characterized salt tolerant strains of Burkholderia cepacia from marine sponges of Saint Martin's Island of the Bay of Bengal, Bangladesh.

<i>Burkholderia pseudomallei</i> Species of bacterium

Burkholderia pseudomallei is a Gram-negative, bipolar, aerobic, motile rod-shaped bacterium. It is a soil-dwelling bacterium endemic in tropical and subtropical regions worldwide, particularly in Thailand and northern Australia. It was reported in 2008 that there had been an expansion of the affected regions due to significant natural disasters, and it could be found in Southern China, Hong Kong, and countries in America. B. pseudomallei, amongst other pathogens, has been found in monkeys imported into the United States from Asia for laboratory use, posing a risk that the pathogen could be introduced into the country.

<i>Burkholderia mallei</i> Species of bacterium

Burkholderia mallei is a Gram-negative, bipolar, aerobic bacterium, a human and animal pathogen of genus Burkholderia causing glanders; the Latin name of this disease (malleus) gave its name to the species causing it. It is closely related to B. pseudomallei, and by multilocus sequence typing it is a subspecies of B. pseudomallei.B. mallei evolved from B. pseudomallei by selective reduction and deletions from the B. pseudomallei genome. Unlike B. pseudomallei and other genus members, B. mallei is nonmotile; its shape is coccobacillary measuring some 1.5–3.0 μm in length and 0.5–1.0 μm in diameter with rounded ends.

Fusobacterium necrophorum is a species of bacteria responsible for Lemierre's syndrome. It has also been known to cause sinusitis, mastoiditis, and odontogenic infections.

<i>Arcanobacterium haemolyticum</i> Species of bacterium

Arcanobacterium haemolyticum is a species of bacteria classified as a gram-positive bacillus. It is catalase-negative, facultative anaerobic, beta-hemolytic, and not motile. It has been known to cause head and neck infections, pharyngitis, and sinusitis.

<i>Burkholderia thailandensis</i> Species of bacterium

Burkholderia thailandensis is a nonfermenting motile, Gram-negative bacillus that occurs naturally in soil. It is closely related to Burkholderia pseudomallei, but unlike B. pseudomallei, it only rarely causes disease in humans or animals. The lethal inoculum is approximately 1000 times higher than for B. pseudomallei. It is usually distinguished from B. pseudomallei by its ability to assimilate arabinose. Other differences between these species include lipopolysaccharide composition, colony morphology, and differences in metabolism.

<i>Bartonella bacilliformis</i> Species of bacterium

Bartonella bacilliformis is a bacterium, Gram negative aerobic, pleomorphic, flagellated, motile, coccobacillary, 2–3 μm long, 0.2–0.5 μm wide, and a facultative intracellular bacterium.

<span class="mw-page-title-main">Ashdown's medium</span>

Ashdown's medium is a selective culture medium for the isolation and characterisation of Burkholderia pseudomallei.

Citrobacter koseri, formerly known as Citrobacter diversus, is a Gram-negative non-spore forming, rod-shaped bacterium. It is a facultative anaerobe capable of aerobic respiration. It is motile via peritrichous flagella. It is a member of the family of Enterobacteriaceae. The members of this family are part of the normal flora and commonly found in the digestive tracts of humans and animals. C. koseri may act as an opportunistic pathogen in individuals who are immunocompromised.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

<i>Clostridium tertium</i> Species of bacterium

Clostridium tertium is an anaerobic, motile, gram-positive bacterium. Although it can be considered an uncommon pathogen in humans, there has been substantial evidence of septic episodes in human beings. C. tertium is easily decolorized in Gram-stained smears and can be mistaken for a Gram-negative organism. However, C.tertium does not grow on selective media for Gram-negative organisms.

<i>Pseudescherichia vulneris</i> Species of bacterium

Pseudescherichia vulneris is a Gram-negative bacterial species. P. vulneris is a fermentative, oxidase-negative, motile rod, which holds characteristics of the family Enterobacteraceae. This bacterium can colonize in the respiratory tract, genital tract, stool, and urinary tract. However, P. vulneris is most often associated with wounds and has been known to colonize open wounds of both humans and animals. This association gave the bacterium its species name, vulneris, which is Latin for wound. It has also been infrequently reported in cases of meningitis. It was identified as Escherichia vulneris in 1982 with a 2017 genomic analysis of its original genus resulting in the creation of its new genus Pseudescherichia.

References

  1. 1 2 3 4 5 6 Ray, P; Sharma, J; Marak, SK; Singhi, S; Taneja, N; Garg, RK (2004). "Chromobacterium violaceum septicaemia from North India". Indian J Med Res. 120 (6): 523–6. PMID   15654137.
  2. Kodach LL, Bos CL, Durán N, Peppelenbosch MP, Ferreira CV, Hardwick JC (2006). "Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells". Carcinogenesis. 27 (3): 508–16. doi: 10.1093/carcin/bgi307 . PMID   16344270.
  3. 1 2 Brazilian National Genome Project Consortium (2003). "The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability". Proc Natl Acad Sci USA. 100 (20): 11660–5. Bibcode:2003PNAS..10011660.. doi: 10.1073/pnas.1832124100 . PMC   208814 . PMID   14500782.
  4. 1 2 Lee, J; Kim, JS; Nahm, CH; Choi, JW; Kim, J; Pai, SH; Moon, KH; Lee, K; Chong, Y (1999). "Two Cases of Chromobacterium violaceum Infection after Injury in a Subtropical Region". J Clin Microbiol. 37 (6): 2068–2070. doi:10.1128/JCM.37.6.2068-2070.1999. PMC   85035 . PMID   10325383.
  5. Itah AY, Essien JP (2005). "Growth Profile and Hydrocarbonoclastic Potential of Microorganisms Isolated from Tarballs in the Bight of Bonny, Nigeria". World Journal of Microbiology and Biotechnology. 21 (6–7): 1317–22. doi:10.1007/s11274-004-6694-z. S2CID   84888286.
  6. de Siqueira IC, Dias J, Ruf H, Ramos EA, Maciel EA, Rolim A, Labur L, Vasconcelos L, Silvany C (2005). "Chromobacterium violaceum in siblings, Brazil". Emerging Infect. Dis. 11 (9): 1443–5. doi:10.3201/eid1109.050278. PMC   3310629 . PMID   16229777.
  7. Sneath, PH; Whelan, JP; Bhagwan Singh, R; Edwards, D (1953). "Fatal infection by Chromobacterium violaceum". Lancet. 265 (6780): 276–7. doi:10.1016/S0140-6736(53)91132-5. PMID   13085740.
  8. M Ravish Kumar. (2012). "Chromobacterium violaceum: A rare bacterium isolated from a wound over the scalp". Int J Appl Basic Med Res. 2 (1): 70–2. doi: 10.4103/2229-516X.96814 . PMC   3657989 . PMID   23776815.
  9. Duran, N; Menck, FM (2001). "Chromobacterium violaceum: A review of pharmacological and industrial perspectives". Crit Rev Microbiol. 27 (3): 201–22. doi:10.1080/20014091096747. PMID   11596879. S2CID   39515820.
  10. Slesak, G; Douangdala, P; Inthalad, S; Silisouk, J; Voungsouath, M; Sengduangphachanh, A; et al. (2009). "Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis". Ann Clin Microbiol Antimicrob. 8: 24. doi: 10.1186/1476-0711-8-24 . PMC   2725030 . PMID   19640274.
  11. Dutta, S; Dutta, SK (2003). "Multidrug resistant chromobacterium violaceum: An unusual bacterium causing long standing wound abscess". Indian J Med Microbiol. 21 (3): 217–8. doi:10.1016/S0255-0857(21)03082-6. PMID   17643028 . Retrieved 6 March 2015.
  12. Chou, YL; Yang ., PY; Huang, CC; Leu, HS; Tsao, TC (2000). "Fatal and non-fatal chromobacterial septicemia: report of two cases". Chang Gung Med J. 23 (8): 492–7. PMID   11039252.
  13. Shao, PL; Hsueh, PR; Chang, YC; Lu, CY; Lee, PY; Lee, CY; Huang, LM (2002). "Chromobacterium violaceum infection in children: a case of fatal septicemia with nasopharyngeal abscess and literature review". Pediatr Infect Dis J. 21 (7): 707–9. doi: 10.1097/00006454-200207000-00022 . PMID   12237610.
  14. Chen, CH; Lin, LC; Liu, CE; Young, TG (2003). "Chromobacterium violaceum bacteremia: a case report". J Microbiol Immunol Infect. 36 (2): 141–4. PMID   12886967.
  15. Inglis, TJ; Chiang, D; Lee, GS; Chor-Kiang, L (1998). "Potential misidentification of Burkholderia pseudomallei by API 20NE". Pathology. 30 (1): 62–64. doi:10.1080/00313029800169685. PMID   9534210. S2CID   31987728.
  16. Lowe, P; Engler, C; Norton, R (2002). "Comparison of Automated and Nonautomated Systems for Identification of Burkholderia pseudomallei". J Clin Microbiol. 40 (12): 4625–7. doi:10.1128/JCM.40.12.4625-4627.2002. PMC   154629 . PMID   12454163.
  17. Groves, MG; Strauss, JM; Abbas, J; Davis, CE (1969). "Natural infections of gibbons with a bacterium producing violet pigment (Chromobacterium violaceum)". J Infect Dis. 120 (5): 605–610. doi:10.1093/infdis/120.5.605. PMID   5388196.
  18. Moore, C; Lane, J; Stephens, J (2001). "Successful treatment of an infant with Chromobacterium violaceum sepsis". Clin Infect Dis. 32 (6): E107–10. doi: 10.1086/319356 . PMID   11247733.
  19. Martinez, R; Velludo, MA; Santos, VR; Dinamarco, PV (2000). "Chromobacterium violaceum infection in Brazil. A case report". Rev Inst Med Trop Sao Paulo. 42 (2): 111–3. doi: 10.1590/s0036-46652000000200008 . PMID   10810326.
  20. Midani, S; Rathore, M (1998). "Chromobacterium violaceum infection". South Med J. 91 (5): 464–466. doi:10.1097/00007611-199805000-00011. PMID   9598856. S2CID   37485951.
  21. Howard, AJ; Ison, CA (1996). "Haemophilus, Gardnerella and other bacilli". In Collee, JG; Fraser, AG; Marmion, BP; Simmons, A (eds.). Mackie and McCartney Practical Medical Microbiology (14th ed.). New York: Churchill Livingstone. pp. 329–41.